The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 8
  • 1
    Batty, Elizabeth Pamela
    Clinical Director born in January 1964
    Individual (2 offsprings)
    Officer
    2024-01-23 ~ now
    OF - director → CIF 0
  • 2
    Mcnish, Andrew Edward
    Solicitor born in October 1966
    Individual (2 offsprings)
    Officer
    2015-11-16 ~ now
    OF - director → CIF 0
  • 3
    Singh, Sukh Dave, Professor
    Doctor born in December 1967
    Individual (2 offsprings)
    Officer
    2004-12-20 ~ now
    OF - director → CIF 0
  • 4
    Vestbo, Jorgen, Professor
    Professor Of Respiratory Medicine born in January 1959
    Individual (3 offsprings)
    Officer
    2018-12-19 ~ now
    OF - director → CIF 0
  • 5
    Rogers, David
    Ceo born in August 1962
    Individual (3 offsprings)
    Officer
    2003-09-08 ~ now
    OF - director → CIF 0
    Rogers, David
    Individual (3 offsprings)
    Officer
    2001-05-21 ~ now
    OF - secretary → CIF 0
  • 6
    Woodcock, Ashley Arthur, Professor
    Professor Of Medicine born in April 1951
    Individual (5 offsprings)
    Officer
    2015-11-16 ~ now
    OF - director → CIF 0
  • 7
    Barber, Philip Vernon, Dr
    Physician born in February 1946
    Individual (2 offsprings)
    Officer
    2000-11-20 ~ now
    OF - director → CIF 0
  • 8
    Nwlc, Southmoor Road, Manchester, England
    Corporate (1 offspring)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 9
parent relation
Company in focus

MEDICINES EVALUATION UNIT LIMITED

Standard Industrial Classification
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
Brief company account
Par Value of Share
Class 1 ordinary share
12023-04-01 ~ 2024-03-31
Class 2 ordinary share
12023-04-01 ~ 2024-03-31
Class 3 ordinary share
12023-04-01 ~ 2024-03-31
Turnover/Revenue
18,166,529 GBP2023-04-01 ~ 2024-03-31
17,573,750 GBP2022-04-01 ~ 2023-03-31
Cost of Sales
-7,509,622 GBP2023-04-01 ~ 2024-03-31
-8,086,711 GBP2022-04-01 ~ 2023-03-31
Gross Profit/Loss
10,656,907 GBP2023-04-01 ~ 2024-03-31
9,487,039 GBP2022-04-01 ~ 2023-03-31
Administrative Expenses
-4,502,885 GBP2023-04-01 ~ 2024-03-31
-4,372,244 GBP2022-04-01 ~ 2023-03-31
Operating Profit/Loss
6,154,022 GBP2023-04-01 ~ 2024-03-31
5,114,795 GBP2022-04-01 ~ 2023-03-31
Other Interest Receivable/Similar Income (Finance Income)
273,893 GBP2023-04-01 ~ 2024-03-31
74,675 GBP2022-04-01 ~ 2023-03-31
Profit/Loss on Ordinary Activities Before Tax
7,086,083 GBP2023-04-01 ~ 2024-03-31
4,976,762 GBP2022-04-01 ~ 2023-03-31
Profit/Loss
7,360,585 GBP2023-04-01 ~ 2024-03-31
5,145,652 GBP2022-04-01 ~ 2023-03-31
Comprehensive Income/Expense
7,360,585 GBP2023-04-01 ~ 2024-03-31
5,145,652 GBP2022-04-01 ~ 2023-03-31
Property, Plant & Equipment
3,920,901 GBP2024-03-31
4,150,986 GBP2023-03-31
Fixed Assets - Investments
6,925,385 GBP2024-03-31
6,090,106 GBP2023-03-31
Fixed Assets
10,846,286 GBP2024-03-31
10,241,092 GBP2023-03-31
Debtors
6,688,361 GBP2024-03-31
7,215,446 GBP2023-03-31
Cash at bank and in hand
19,504,181 GBP2024-03-31
16,627,503 GBP2023-03-31
Current Assets
26,192,542 GBP2024-03-31
23,842,949 GBP2023-03-31
Net Current Assets/Liabilities
23,838,585 GBP2024-03-31
20,056,308 GBP2023-03-31
Total Assets Less Current Liabilities
34,684,871 GBP2024-03-31
30,297,400 GBP2023-03-31
Net Assets/Liabilities
34,636,650 GBP2024-03-31
30,226,961 GBP2023-03-31
Equity
Called up share capital
975 GBP2024-03-31
975 GBP2023-03-31
975 GBP2022-03-31
Share premium
264,177 GBP2024-03-31
264,177 GBP2023-03-31
14,697 GBP2022-03-31
Retained earnings (accumulated losses)
34,371,498 GBP2024-03-31
29,961,809 GBP2023-03-31
26,267,854 GBP2022-03-31
Equity
34,636,650 GBP2024-03-31
30,226,961 GBP2023-03-31
26,283,526 GBP2022-03-31
Issue of Equity Instruments
249,480 GBP2022-04-01 ~ 2023-03-31
Dividends Paid
Retained earnings (accumulated losses)
-2,950,896 GBP2023-04-01 ~ 2024-03-31
-1,451,697 GBP2022-04-01 ~ 2023-03-31
Dividends Paid
-2,950,896 GBP2023-04-01 ~ 2024-03-31
-1,451,697 GBP2022-04-01 ~ 2023-03-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
7,360,585 GBP2023-04-01 ~ 2024-03-31
5,145,652 GBP2022-04-01 ~ 2023-03-31
Wages/Salaries
6,181,738 GBP2023-04-01 ~ 2024-03-31
5,862,295 GBP2022-04-01 ~ 2023-03-31
Social Security Costs
624,781 GBP2023-04-01 ~ 2024-03-31
650,043 GBP2022-04-01 ~ 2023-03-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
263,810 GBP2023-04-01 ~ 2024-03-31
219,355 GBP2022-04-01 ~ 2023-03-31
Staff Costs/Employee Benefits Expense
7,070,329 GBP2023-04-01 ~ 2024-03-31
6,731,693 GBP2022-04-01 ~ 2023-03-31
Average Number of Employees
1492023-04-01 ~ 2024-03-31
1622022-04-01 ~ 2023-03-31
Director Remuneration
483,116 GBP2023-04-01 ~ 2024-03-31
387,070 GBP2022-04-01 ~ 2023-03-31
Property, Plant & Equipment - Depreciation Expense
Owned assets
243,793 GBP2023-04-01 ~ 2024-03-31
242,832 GBP2022-04-01 ~ 2023-03-31
Audit Fees/Expenses
8,000 GBP2023-04-01 ~ 2024-03-31
11,700 GBP2022-04-01 ~ 2023-03-31
Current Tax for the Period
-252,284 GBP2023-04-01 ~ 2024-03-31
-197,850 GBP2022-04-01 ~ 2023-03-31
Tax Expense/Credit at Applicable Tax Rate
1,771,521 GBP2023-04-01 ~ 2024-03-31
945,585 GBP2022-04-01 ~ 2023-03-31
Dividends Paid on Shares
2,950,896 GBP2023-04-01 ~ 2024-03-31
1,451,697 GBP2022-04-01 ~ 2023-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
944,065 GBP2024-03-31
944,065 GBP2023-03-31
Furniture and fittings
570,612 GBP2024-03-31
556,904 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
832,373 GBP2024-03-31
765,324 GBP2023-03-31
Furniture and fittings
470,495 GBP2024-03-31
430,809 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
67,049 GBP2023-04-01 ~ 2024-03-31
Furniture and fittings
39,686 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment
Plant and equipment
111,692 GBP2024-03-31
178,741 GBP2023-03-31
Furniture and fittings
100,117 GBP2024-03-31
126,095 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
Motor vehicles
6,959 GBP2024-03-31
6,959 GBP2023-03-31
Computers
247,288 GBP2024-03-31
247,288 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
7,284,057 GBP2024-03-31
7,270,349 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Motor vehicles
6,959 GBP2024-03-31
6,959 GBP2023-03-31
Computers
247,288 GBP2024-03-31
247,288 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
3,363,156 GBP2024-03-31
3,119,363 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
243,793 GBP2023-04-01 ~ 2024-03-31
Trade Debtors/Trade Receivables
Current
3,539,918 GBP2024-03-31
2,297,338 GBP2023-03-31
Amounts Owed by Group Undertakings
Current
564,239 GBP2024-03-31
1,206,115 GBP2023-03-31
Other Debtors
Current
79,124 GBP2023-03-31
Amount of corporation tax that is recoverable
Current
495,043 GBP2024-03-31
823,281 GBP2023-03-31
Called-up share capital (not paid)
Current
110,916 GBP2024-03-31
110,916 GBP2023-03-31
Prepayments/Accrued Income
Current
531,075 GBP2024-03-31
13,031 GBP2023-03-31
Debtors
Current, Amounts falling due within one year
6,688,361 GBP2024-03-31
7,215,446 GBP2023-03-31
Trade Creditors/Trade Payables
Current
32,677 GBP2024-03-31
11,594 GBP2023-03-31
Other Taxation & Social Security Payable
Current
147,892 GBP2024-03-31
47,783 GBP2023-03-31
Accrued Liabilities/Deferred Income
Current
1,971,370 GBP2024-03-31
3,559,133 GBP2023-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
133,866 GBP2024-03-31
108,985 GBP2023-03-31
Between one and five year
354,115 GBP2024-03-31
245,535 GBP2023-03-31
More than five year
304,512 GBP2024-03-31
285,973 GBP2023-03-31
All periods
792,493 GBP2024-03-31
640,493 GBP2023-03-31
Deferred Tax Liabilities
Accelerated tax depreciation
48,221 GBP2024-03-31
70,439 GBP2023-03-31
Amounts set aside to cover potential liabilities or losses
Deferred taxation
48,221 GBP2024-03-31
70,439 GBP2023-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
828 shares2024-03-31
Class 2 ordinary share
39 shares2024-03-31
Profit/Loss
Retained earnings (accumulated losses)
7,360,585 GBP2023-04-01 ~ 2024-03-31
  • MEDICINES EVALUATION UNIT LIMITED
    Info
    Registered number 03779957
    The Langley Building, Southmoor, Road, Wythenshawe, Manchester M23 9QZ
    Private Limited Company incorporated on 1999-05-28 (26 years). The company status is Active.
    The last date of confirmation statement was made at 2024-05-28
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.